TheProfitWatch

ALDX - Aldeyra Therapeutics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.38 0.29 (5.39%) --- --- --- 0.0 (0.0%) 0.33 (6.18%) 0.0 (0.0%) 0.08 (1.51%)

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.16
Diluted EPS:
-0.16
Basic P/E:
-35.4375
Diluted P/E:
-35.4375
RSI(14) 1m:
80.0
VWAP:
5.67
RVol:
0.7093

Events

Period Kind Movement Occurred At

Related News